Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
 

Investors

+

Main navigation

Main navigation

  • News - Press releases
  • Financial Calendar
  • Financial reports
    • IPO and listning documents
  • Corporate governance
    • Articles Of Association
    • AGM and Extraordinary general meetings
      • Annual General Meeting on May 5 2022
      • Annual general meeting on 5 May 2021
      • Extraordinary Shareholders Meeting 19 November
      • Extraordinary general meeting January 2020
      • Annual General Meeting, May 20, 2020
    • Auditor
    • Nomination Committee
    • Certified adviser
  • Share information
    • Major shareholders
    • Sharecapital
    • Incentive programme
    • Dividend Policy
    • Warrants (TO)
  • Board
  • Management
  • Insiders
  • IR Contact
  • Presentations

Board

Thomas Warthoe (board)

Thomas Warthoe

Born: 1967
Main occupation: CEO Qlife Aps
Shares: 1 507 053 
Options: none

Member of the board since 2020

Entrepreneur with over 20 years of experience in the healthcare industry (and specifically diagnostics). Thomas has founded and developed three biotech companies. In two of the companies Thomas founded, Display System Biotech and Ampligon, successful exits were made. He has successfully entered strategic partnerships and licensing agreements with global diagnostic companies such as Backman Coulter, Shionogi Co and Omron Healthcare over the years.

Dependent of the company and its management and major shareholders.

Other assignments: Board member of Petel Holding A/S, PKV Consult IVS and Chip Diagnostics Inc.

Mette Gross

Mette Gross

Born: 1972
Main occupation: own
Shares: 67 766
Warrants series 2019/2022: 129 629

Chairman since 2019

Mette has 20 years of experience from small and large companies as CFO. In recent years, Mette has been involved in the development and listing of two medical technology companies and a SaaS company alongside work with own investments and change management assignments. Mette has an educational background as Master of Finance and Mathematics from Odense University. Previous assignments include: CFO Iconovo AB, CFO Vigmed Holding AB, Director Controlling Coloplast Group and CFO MTG A/S.

Independent of the company and its management and major shareholders.

Other assignments: Board member of Anatomic Studios AB, Holm Holding AB (and subsidiaries), MLH Management AB (and subsidiaries) and Queen Invest AB.

John Moll

John Moll

Born: 1978
Main occupation: own
Shares:144 024
Warrants series 2019/2022: 64 815

Member of the board since 2018 (Qlife Aps 2018-2019)

John Moll is a Swedish entrepreneur and experienced business angel with a focus on Life Science. John has an educational background as a pharmaceutical chemist from the Faculty of Engineering at Lund University. John has founded and sold two companies and is a board member of three biotech companies in Sweden and Denmark.

Independent of the company and its management and major shareholders.

Other assignments: Board member of Spermosens AB, TIRmed Pharma and Torna Kapital AB.

Ulrik Harrysson

Born: 1969
Main occupation: CEO of SyntheticMR 
Shares: 2 000 
Warrants series 2021/24: 15 000

Board member since 2021

CEO of SyntheticMR since 2019. Previous roles, during a more than 25-year long career, include international management roles in global companies such as Hermes Medical Solution, HemoCue, Danaher and Pfizer. Ulrik has a master’s degree in Business Administration, specialization in Marketing, from the International Business School in Jönköping.

Independent of the company and its management and major shareholders.

Other assignments: None.
 

Mikael Persson

Born: 1967
Main occupation: EVP Supply Chain & Operations and Product Development Arjo
Shares:10 000
Warrants series 2021/24: 25 000

Board member since 2021

8 years global experience in the Med Tech industry in senior positions in Supply Chain and Product Development. Participated and ran several major product developments in collaboration with third parties globally. Previous experience of various positions within Alfa Laval, including VP Operations – Operations Development Manager, Supply Chain Director for Cardo Flow Solutions and Flûgger A/S, VP Supply Chain ArjoHuntleigh AB and COO Manufacturing Capital Equipment Getinge

Independent of the company and its management and major shareholders.
Other assignments: None.
 

Mette-Marie Harild

Born: 1958
Main occupation: own
Shares: none
Warrants: none

Board member since 2021

Mette-Marie Harild has a long experience of leading international organizations within the pharma/medical industry, most recently from Medtronic as Regional Vice President ABGI & Nordic. Mette-Marie has a strong focus on customers, sales and change management and has vast experiences of public/private cooperation and purchases. 

Mette-Marie is originally a trained dentist and has an Executive MBA in Change Management. 

Independent of the company and its management and major shareholders.

Other assignments:
Neurescue och Occlutech

Chairman of AmCham Healthcare Committee and the Danish Chamber of Commerce Life Science Board, and member of the Danish Chamber of Commerce and the Danish Business Development Board under the Ministry of Commerce (Danish Erhvervsfremmebestyrelse)
 

Qlife

Qlife Holding AB
Redaregatan 48
SE-252 36 Helsingborg, Sweden
info@egoo.health

Links

  • About
  • Investors
  • Egoo.health

Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarker and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information that can contribute to better treatment and potential prevention of diseases is facilitated. On March 2, 2020, Qlife Holding completed a listing on the Nasdaq First North Growth Market, Stockholm. The company currently has about 40 employees.